INFORMATION:
About the IASLC:
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes nearly 7,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.
About the WCLC:
The WCLC is the world's largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 countries. The goal is to increase awareness, collaboration and understanding of lung cancer, and to help participants implement the latest developments across the globe. The conference will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more information, visit wclc2020.iaslc.org. END
Sotorasib provides durable clinical benefit for patients with NSCLC and KRAS mutations
Exciting new research to be presented at international association for the study of lung cancer world conference on lung cancer's presidential symposium
2021-01-28
(Press-News.org) (For Immediate Release--Singapore--January 28, 2021)-- In the phase II CodeBreak 100 trial, sotorasib provided durable clinical benefit with a favorable safety profile in patients with pretreated non-small cell lung cancer (NSCLC) and who harbor KRAS p.G12C mutations, validating CodeBreak 100's phase I results, according to research presented today at the International Association for the Study of Lung Cancer World Conference on Lung Cancer.
Outcome in patients with advanced NSCLC on second- or third-line therapies is poor, with a response rate of less than 20% and median progression-free survival of fewer than four months. Approximately 13% of patients with lung adenocarcinomas harbor KRAS p.G12C mutations.
Sotorasib is a first-in-class small molecule that specifically and irreversibly inhibits KRAS p.G12C. In the phase I cohort of the CodeBreak 100 trial, sotorasib was well tolerated and demonstrated a confirmed response rate of 32.2%, a median duration of response of 10.9 months, and a median progression-free survival of 6.3 months in 59 patients with heavily pretreated NSCLC.
Results from the registrational phase II portion of this multicenter, international study, led by Dr. Bob Li, of Memorial Sloan Kettering Cancer Center in New York City, were presented for the first time.
Researchers enrolled 126 patients who met the following inclusion criteria:
Presence of a centrally confirmed KRAS p.G12C mutation;
Disease progression on anti-PD-1/PD-L1 immunotherapy and/or platinum-based combination chemotherapy, or targeted therapy if EGFR, ALK, and ROS1 alterations had been previously identified; and
Fewer than or equal to three prior lines of therapy.
Patients with untreated active brain metastases were excluded.
Enrolled patients were followed for a median period of 12.2 months. An independent blinded central review of the patients found that 124 patients had at least one measurable lesion at baseline and were evaluated for efficacy. Of these, 46 patients experienced a confirmed response (three complete responses and 43 partial responses), resulting in an objective response rate of 37.1% (95% Cl: 28.6-46.2). The median time to objective response was 1.4 months, the median duration of response was 10 months (95% CI: 6.9-11.1), and 43% of responders remained on treatment without progression. The disease control rate was 80.6% (95% Cl: 72.6-87.2).
Median progression-free survival was 6.8 months (95% Cl: 5.1-8.2).
Treatment-related adverse events (TRAEs) of any grade occurred in 88 (69.8%) patients and led to discontinuation in nine (7.1%) patients. Grade 3 TRAEs were reported in 25 (19.8%) patients; those that occurred most commonly were alanine aminotransferase increase (8/126, 6.3%), aspartate aminotransferase increase (7/126, 5.6%), and diarrhea (5/126, 4.0%). There were no treatment-related deaths.
"This is a historic milestone in [lung] cancer therapy. After four decades of scientific efforts in targeting KRAS, sotorasib has potential to be the first targeted treatment option for this patient population with a high unmet need," said Dr. Li.
Further clinical trials of sotorasib, either alone or in combination with other cancer drugs, are ongoing in an effort to benefit more patients.
In December 2020, Amgen submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) and Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for sotorasib, for the treatment of patients with KRAS p.G12C-mutated locally advanced or metastatic NSCLC, following at least one prior systemic therapy. The NDA is being reviewed under the FDA's Real-Time Oncology Review pilot program and has been granted Breakthrough Therapy designation.
ELSE PRESS RELEASES FROM THIS DATE:
Researchers reveal in-situ manipulation of active Au-TiO2 interface
2021-01-28
An international joint research team from the Shanghai Advanced Research Institute of the Chinese Academy of Sciences, along with Zhejiang University and the Technical University of Denmark, reported an in-situ strategy to manipulate interfacial structure with atomic precision during catalytic reactions. Results were published in the latest issue of Science.
The interface between nanoparticles and substrates plays a critical role in heterogeneous catalysis because most active sites are located at the perimeter of the interface. It is generally believed that this interface is immobile and unchangeable, thus can hardly be adjusted in reactive environments. As a result, it has been challenging to promote catalytic activity through precise control of the interfacial ...
Viral sequencing can reveal how SARS-CoV-2 spreads and evolves
2021-01-28
The emergence of SARS-CoV-2 virus variants that are adding twists in the battle against COVID-19 highlight the need for better genomic monitoring of the virus, says Katia Koelle, associate professor of biology at Emory University.
"Improved genomic surveillance of SARS-CoV-2 across states would really help us to better understand how the virus causing the pandemic is evolving and spreading in the United States," Koelle says. "More federal funding is needed, along with centralized standards for sample collection and genetic sequencing. Researchers need access to such metadata to better track how the virus is spreading geographically, and to identify any new variants ...
Screening asymptomatic health care personnel for COVID-19 not recommended by experts
2021-01-28
BOSTON -- Routine screening of asymptomatic health care personnel (HCP) in the absence of confirmed exposures to COVID-19 is not a recommended strategy for preventing transmission of the coronavirus causing the current global pandemic, according to a new review co-authored by an infectious disease specialist at Massachusetts General Hospital (MGH). The review, published in Infection Control & Hospital Epidemiology, found that such testing is unlikely to affect the transmission of SARS-CoV-2 in health care settings and could even have unintended negative consequences.
Many universities, sports leagues and other institutions require individuals in their organization to undergo routine testing for COVID-19, whether or not they are experiencing symptoms. Current public ...
Marine heatwaves becoming more intense, more frequent
2021-01-28
When thick, the surface layer of the ocean acts as a buffer to extreme marine heating--but a new study from the University of Colorado Boulder shows this "mixed layer" is becoming shallower each year. The thinner it becomes, the easier it is to warm. The new work could explain recent extreme marine heatwaves, and point at a future of more frequent and destructive ocean warming events as global temperatures continue to climb.
"Marine heatwaves will be more intense and happen more often in the future," said Dillon Amaya, a CIRES Visiting Fellow and lead author on the study out ...
Counties with more cannabis dispensaries show reduced opioid deaths
2021-01-28
Counties with a greater number of cannabis dispensary storefronts experience reduced numbers of opioid-related deaths relative to other locales, a recent University of California, Davis, study has found. This is the first study to examine the association between active cannabis dispensary operations -- both medical and recreational -- and opioid-related mortality rates at the county level, suggesting that providing alternative pain management could improve public health outcomes, researchers said.
"While the associations documented cannot be assumed to be causal, they suggest a potential relationship between increased prevalence of medical and recreational cannabis dispensaries and reduced opioid-related ...
Mechanism for how pancreatic cancer evades immunotherapy elucidated
2021-01-28
WASHINGTON --- Pancreatic cancer, one of the most lethal of all cancers, is capable of evading attacks by immune cells by changing its microenvironment so that the immune cells suppress, rather than support, an attack on the tumor. The scientists also found that that some of the mediators of this suppressive response, including a protein called STAT1, represent potential therapeutic targets that could be used to reverse this evasion and point to possible treatment opportunities.
The finding appears January 28, 2021, in Cancer Immunology Research.
"This ...
New study unravels Darwin's 'abominable mystery' surrounding origin of flowering plants
2021-01-28
The origin of flowering plants famously puzzled Charles Darwin, who described their sudden appearance in the fossil record from relatively recent geological times as an "abominable mystery". This mystery has further deepened with an inexplicable discrepancy between the relatively recent fossil record and a much older time of origin of flowering plants estimated using genome data.
Now a team of scientists from Switzerland, Sweden, the UK, and China may have solved the puzzle. Their results show flowering plants indeed originated in the Jurassic or earlier, that is millions of years earlier than their oldest undisputed fossil evidence, according to a new study published in the scientific journal Nature Ecology & Evolution. The lack of older ...
Loggerhead sea turtles lay eggs in multiple locations to improve reproductive success
2021-01-28
Although loggerhead sea turtles return to the same beach where they hatched to lay their eggs, a new study by a USF professor finds individual females lay numerous clutches of eggs in locations miles apart from each other to increase the chance that some of their offspring will survive.
A study published in the journal "Scientific Reports" found that some females lay as many as six clutches as far as six miles apart during the same breeding season.
"Nesting females don't lay all their eggs in one basket. Their reproductive strategy is like investing in a mutual fund. Females divide their resources among many stocks rather than investing everything in a single stock," said Deby Cassill, biology professor ...
Nanoparticle drug delivery technique shows promise for treating pancreatic cancer
2021-01-28
Researchers with the Kansas City Veterans Affairs Medical Center and North Dakota State University have designed a new way to deliver pancreatic cancer drugs that could make fighting the disease much easier. Encapsulating cancer drugs in nanoparticles shows potential to target tumors more effectively and avoid danger to other parts of the body.
The study results appeared in the Jan. 4, 2021, issue of the journal Molecular Pharmaceutics.
Study author Dr. Sushanta Banerjee, a researcher with the Kansas City VA and University of Kansas medical centers, explains that this technology has the potential to drastically improve Veterans' cancer care. "Veteran health care will benefit immensely from such therapeutic models, as they are ...
Chemists settle battery debate, propel research forward
2021-01-28
UPTON, NY--A team of researchers led by chemists at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory has identified new details of the reaction mechanism that takes place in batteries with lithium metal anodes. The findings, published today in Nature Nanotechnology, are a major step towards developing smaller, lighter, and less expensive batteries for electric vehicles.
Recreating lithium metal anodes
Conventional lithium-ion batteries can be found in a variety of electronics, from smartphones to electric vehicles. While lithium-ion batteries have enabled the widespread use of many technologies, they still face challenges in powering electric vehicles over ...
LAST 30 PRESS RELEASES:
New film highlights the hidden impact of climate change on brain health
Conservation leaders challenge global economic systems that value ‘dead’ nature over living planet
A multidimensional diagnostic approach for COPD
Wearable sensor could be used to monitor OSA treatment response
Waitlist deaths dropped under new lung transplant allocation system
Methotrexate as effective as prednisone in pulmonary sarcoidosis
Waist-to-height ratio predicts heart failure incidence
Climate change increases severity of obstructive sleep apnea
USC, UCLA team up for the world’s first-in-human bladder transplant
Two out of five patients with heart failure do not see a cardiologist even once a year and these patients are more likely to die
AI-enabled ECG algorithm performs well in the early detection of heart failure in Kenya
No cardiac safety concerns reported with a pharmaceutically manufactured cannabidiol formulation
Scientists wash away mystery behind why foams are leakier than expected
TIFRH researchers uncover a mechanism enabling glasses to self-regulate their brittleness
High energy proton accelerator on a table-top — enabled by university class lasers
Life, death and mowing – study reveals Britain’s poetic obsession with the humble lawnmower
Ochsner Transplant Institute’s kidney program achieves ELITE Status
Gender differences in primary care physician earnings and outcomes under Medicare Advantage value-based payment
Can mindfulness combat anxiety?
Could personality tests help make bipolar disorder treatment more precise?
Largest genomic study of veterans with metastatic prostate cancer reveals critical insights for precision medicine
UCF’s ‘bridge doctor’ combines imaging, neural network to efficiently evaluate concrete bridges’ safety
Scientists discover key gene impacts liver energy storage, affecting metabolic disease risk
Study finds that individual layers of synthetic materials can collaborate for greater impact
Researchers find elevated levels of mercury in Colorado mountain wetlands
Study reveals healing the ozone hole helps the Southern Ocean take up carbon
Ultra-robust hydrogels with adhesive properties developed using bamboo cellulose-based carbon nanomaterials
New discovery about how acetaminophen works could improve understanding about pain relievers
What genetic changes made us uniquely human? -- The human intelligence evolved from proximal cis-regulatory saltations
How do bio-based amendments address low nutrient use efficiency and crop yield challenges?
[Press-News.org] Sotorasib provides durable clinical benefit for patients with NSCLC and KRAS mutationsExciting new research to be presented at international association for the study of lung cancer world conference on lung cancer's presidential symposium